ArticleFrontiers in pharmacology2026

Visomitin as a differentiation-inducing therapeutic agent through SYK inhibition in AML.

Byeol-Eun Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.